A randomized open-labelled comparative clinical study to evaluate the efficacy of Navanga Kwath with Vitamin E in the management of Non-Alcoholic Fatty Liver Disease(Yakritroga) - NI

INSTITUTE FOR AYURVED STUDIES AND RESEARCH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1. The patient presented with cardinal features of Yakritroga as described in Ayurvedic
•2. Randomly selected irrespective of their caste, religion and sex.
•3. Patient with the age group of age of 25-60 years.
•4. Voluntary agreement & and enrolment to participate in the study.
•5. The ratio of AST/ALT below 2.
•6. Non-alcoholic Fatty Liver Disease patient who was diagnosed by abdomen ultrasonic
•examination and non-drinker or total abstainer or with alcohol intake of less than 20 gm
•per day for females and less than 30 gm per day for males.
•7. NAFLD confirmed by USG with or without having symptoms like fatigue and mild
•discomfort in the upper quadrant of the abdomen.
•8. Both freshly detected & and previously diagnosed cases of NAFLD.

•1 Patient below 25 years and above 60 years of age
•2 The ratio of AST or ALT over 2
•3 Metabolic syndromes such as Type I and II Diabetes Mellitus Hypertension
•Cerebrovascular Accident Myocardial Infarction and Chronic Kidney Disease
•4 Any dysfunction of the liver besides Non Alcoholic Fatty Liver Diseases like Viral Hepatitis Liver Parenchymal Disease Ascites portal Hypertension Hepato Cellular Carcinoma Auto Immune Hepatitis Primary Biliary Cirrhosis Wilsons Disease and liver Transplantation or any other conditions interfering with the result of the treatment of non alcoholic fatty liver disease patient
•5. Prior treatment with any medicine that affects the treatment of Non Alcoholic Fatty Liver Disease within 3 months
•6 Patient suffering from HIV TB other infectious diseases Malignancies Major
•Psychiatric Problems or any other serious problems
•7. Patient on prolonged (more than 6 weeks) medication with corticosteroids antidepressants anti cholinergic hepatotoxic medicines or any other drug that may influence the outcome of The study
•8 Alcoholics and any other drug abusers
•9 Pregnant and Lactating women
•10 The patient has a history of Hypersensitivity to the trial drug or any of its ingredients

发起方

INSTITUTE FOR AYURVED STUDIES AND RESEARCH